Ethical considerations for choosing between possible models for using NIPD for aneuploidy detection
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis
- Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down’s syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units
- Non-invasive prenatal testing for aneuploidy screening
- Non-invasive prenatal diagnosis: progress and potential
- Women’s choices in non-invasive prenatal testing for aneuploidy screening: results from a single centre prior to introduction in England
- Introducing the non-invasive prenatal testing for detection of Down syndrome in China: a cost-effectiveness analysis
- Should pregnant women be charged for non-invasive prenatal screening? Implications for reproductive autonomy and equal access
- Ethics of routine: a critical analysis of the concept of ‘routinisation’ in prenatal screening
- Cell-free fetal DNA and RNA in maternal blood: implications for safer antenatal testing
- Non-invasive prenatal testing in mitigating concerns from invasive prenatal diagnostic testing: retrospective assessment of utility in an academic healthcare system in the US